(Q40468596)

20 September 2017

title

Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. (English)

1 reference

20 September 2017

1 reference

Myxoma virus

1 reference

4

Grant McFadden

1 reference

20 September 2017

J B Johnston

1

1 reference

20 September 2017

Steven H Nazarian

series ordinal

2

1 reference

20 September 2017

Renato Natale

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

332

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

235-248

1 reference

Soluble interferon-gamma receptors encoded by poxviruses

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

On the role of IRF in host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Immunomodulatory proteins of myxoma virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Current infection-control issues for smallpox disease and vaccinia vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Poxvirus vaccines for cancer and HIV therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Studies on vaccinia virus plaque formation and its inhibition by interferon. II. Dynamics of plaque formation by vaccinia virus in the presence of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Signalling in viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Vaccinia as a vector for gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Role of the serine-threonine kinase PAK-1 in myxoma virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Sensitive interferon assay based on immunoenzymatic quantification of viral antigen synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Viruses and interferon: a fight for supremacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Immune responses to myxoma virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Production of interferon in human diploid cells at different population doubling levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Use of chemokine receptors by poxviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Studies on vaccinia virus plaque formation and its inhibition by interferon. III. A simplified plaque inhibition assay of interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Mitotic misregulation and human aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Induction and regulation of IFNs during viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Poxvirus infection rapidly activates tyrosine kinase signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

PACT, a protein activator of the interferon-induced protein kinase, PKR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Cellular receptors for viruses: links to tropism and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Poxviruses and immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Multiple signaling pathways leading to the activation of interferon regulatory factor 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Induction of human leukocyte interferon by heat-treated poly I: poly C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Immunology. A viral on/off switch for interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

Quantitative aspects of interferon-induced plaque reduction: effects of cell age and dose of challenge virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

7 January 2021

Intrinsic interference: a new type of viral interference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

7 January 2021

Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

7 January 2021

Selection of New Human Foreskin Fibroblast Cell Strains for Interferon Production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.11.030

7 January 2021

10.1016/J.VIROL.2004.11.030

Identifiers

DOI

1 reference

20 September 2017

1 reference